ADJUVATIS

Pdf

ADJUVATIS

Category

  • Start-up

Location

  • 69007
  • Lyon
  • France

Medias

Activity

  • Formulation of active ingredients to:
    - solubilize hydrophobic active ingredients,
    - protect drugs from degradations,
    - target organs/cells of therapeutic interest.
    Formulation in biodegradable synthetic polymeric particles "safe-by-design", fully metabolizable. Human & Animal Health

Participants

BV avatar

Bernard VERRIER

Laboratory Director

Landmarks

  • Turnover : NC.
  • Staff : 0 - 9

Group / Member of

  • European Training Network - DRIVE Autophagy (2017-2020)
  • ANR ASIO (2014-2018)
  • ANR PANACEE (2014-2017)

Objectives

Offers

  •  R&D
  •  Patents / Licenses
  •  Studies and engineering
  • Technology Platform
  • Technical service / equipment

Needs

  •  R&D
  • Public support for innovation
  • Financing Innovation
  • Technical service / equipment

SPECIFIC INFORMATION ON THE NATURE OF THE OFFER

Service offer: development of active ingredient formulation, for applications in human health:
- liver diseases (NASH, cancers, etc.)
- cosmetology / dermatology (antibiotics, antioxidants)
- treatment of skin wounds
- vaccines (human & veterinary) - antigen formulation
Fifteen years of R&D have enabled us to develop a technology of synthetic particles "safe-by-design", evaluated by third parties for various therapeutic applications.

Your technological assets

  • Formlation of anti-cancer drugs (in vitro & in vivo evaluations)
  • Formulation of antibiotics (in vitro evaluations in vivo ongoing))
  • Formulation of anti-oxydants (in vitro & in vivo evaluations)
  • Formulation of immune modulators (TLR / Nod ligands), (in vitro & in vivo evaluations)
  • Efficient targeting of liver evaluated in vivo thanks to fluorescent particles

Application fields

  • Application fields
  • Agriculture, Livestock
  • Defence
  • Health - Health Technologies
  • Health - Pharmacy - Biotechnology

EQUIPMENTS, TECHNOLOGIES AND PROCESSES

  • Development of methods of drugs quantification
  • Development of drugs formulations
  • Evaluations in vitro on eucaryotic and procaryotic cells (toxicity, simple efficacy assays)
  • Fluorescent particles

Certifications

References

  • CNRS, CEA, INSERM, INRA, SATT,

Skills

4. Chemistry
  • 4.2 Organic chemistry and biochemistry
  • Biochemistry
  • Specialty chemistry, cosmetics
  • 4.3 Polymers
  • Sol-gel, nanoparticles
  • 4.5 Processes
  • Formulation
9. Medical and health technologies
  • 9.1 Investigation
  • Basic biology: molecular biology, genetics, microbiology, parasitology, virology …
  • Biotechnologies
  • Signal treatment, imaging
  • 9.2 Therapeutics
  • Bio-materials, implants
  • Drug-delivery
  • Regenerative medicine
  • 9.6 Imaging
  • In vivo imaging
  • Probes
  • 9.8 Modeling
  • Animal models
  • Cellular models
12. Agriculture
  • 12.1 Agriculture
  • Green biotechnology
  • Animal Health
14. Support for innovation and R & D partnerships
  • 14.1 Support for innovation and R & D partnerships
  • European Collaborative Project – Mission enterprise European Network